South & Central America Organoids Market
Historic Data:    |   Base Year: 2023   |   Forecast Period: 2024-2031
Forecast to 2030 - Regional Analysis - by Organ Type (Intestine, Liver, Stomach, Pancreas, Lung, Brain, Kidney, and Others), Application (Development of Biology Disease, Pathology of infectious Disease, Regenerative Medicines, Drug Discovery and Personalized Medicine, Drug Toxicity and Efficacy Testing, and Others), Source (Pluripotent Stem Cell and Organ Specific Adult Stem Cell), and Type (Instruments, Consumables, and Services)

No. of Pages: 82    |    Report Code: BMIRE00028764    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
South & Central America Organoids Market
Free Sample Buy Now

1. Introduction

1.1 Business Market Insights Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights
2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
  • 3.2.1 Hypothesis formulation:
  • 3.2.2 Macro-economic factor analysis:
  • 3.2.3 Developing base number:
  • 3.2.4 Data Triangulation:
  • 3.2.5 Country level data:

4. South & Central America Organoids Market Landscape

4.1 Market Overview
4.2 Porter's Five Forces Analysis
  • 4.2.1 Bargaining Power of Suppliers
  • 4.2.2 Bargaining Power of Buyers
  • 4.2.3 Threat of New Entrants
  • 4.2.4 Competitive Rivalry
  • 4.2.5 Threat of Substitutes
4.3 Ecosystem Analysis
  • 4.3.1 Raw Material Suppliers
  • 4.3.2 Manufacturers
  • 4.3.3 Distributors/Suppliers
  • 4.3.4 End Users

5. South & Central America Organoids Market – Key Market Dynamics

5.1 Growth Drivers
  • 5.1.1 The organoid services market is experiencing rapid growth owing to the increasing demand for innovative screening services.
5.2 Market Opportunities
  • 5.2.1 Increasing key developments, launches, and strategic collaborations among market players create ample opportunities for the organoid services market growth
5.3 Future Trends
  • 5.3.1 AI-driven automation can revolutionize organoid production and research workflows
5.4 Impact of Drivers and Restraints

6. South & Central America Organoids Market Regional Analysis

6.1 South & Central America Organoids Market Overview
6.2 South & Central America Organoids Market Revenue 2020-2030 (US$ Million)
6.3 South & Central America Organoids Market Forecast Analysis

7. South & Central America Organoids Market Analysis – by Organ Type

7.1 Intestine
  • 7.1.1 Overview
  • 7.1.2 Intestine: South & Central America Organoids Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Liver
  • 7.2.1 Overview
  • 7.2.2 Liver: South & Central America Organoids Market – Revenue and Forecast to 2031 (US$ Million)
7.3 Stomach
  • 7.3.1 Overview
  • 7.3.2 Stomach: South & Central America Organoids Market – Revenue and Forecast to 2031 (US$ Million)
7.4 Pancreas
  • 7.4.1 Overview
  • 7.4.2 Pancreas: South & Central America Organoids Market – Revenue and Forecast to 2031 (US$ Million)
7.5 Lung
  • 7.5.1 Overview
  • 7.5.2 Lung: South & Central America Organoids Market – Revenue and Forecast to 2031 (US$ Million)
7.6 Brain
  • 7.6.1 Overview
  • 7.6.2 Brain: South & Central America Organoids Market – Revenue and Forecast to 2031 (US$ Million)
7.7 Kidney
  • 7.7.1 Overview
  • 7.7.2 Kidney: South & Central America Organoids Market – Revenue and Forecast to 2031 (US$ Million)

8. South & Central America Organoids Market Analysis – by Application

8.1 Development of Biology Disease
  • 8.1.1 Overview
  • 8.1.2 Development of Biology Disease: South & Central America Organoids Market – Revenue and Forecast to 2030 (US$ Million)
8.2 Pathology of infectious Disease
  • 8.2.1 Overview
  • 8.2.2 Pathology of infectious Disease: South & Central America Organoids Market – Revenue and Forecast to 2030 (US$ Million)
8.3 Regenerative Medicines
  • 8.3.1 Overview
  • 8.3.2 Regenerative Medicines: South & Central America Organoids Market – Revenue and Forecast to 2030 (US$ Million)
8.4 Drug Discovery and Personalized Medicine
  • 8.4.1 Overview
  • 8.4.2 Drug Discovery and Personalized Medicine: South & Central America Organoids Market – Revenue and Forecast to 2030 (US$ Million)
8.5 Drug Toxicity and Efficacy Testing
  • 8.5.1 Overview
  • 8.5.2 Drug Toxicity and Efficacy Testing: South & Central America Organoids Market – Revenue and Forecast to 2030 (US$ Million)

9. South & Central America Organoids Market Analysis – by Source

9.1 Pluripotent Stem Cell
  • 9.1.1 Overview
  • 9.1.2 Drug Toxicity and Efficacy Testing: South & Central America Organoids Market – Revenue and Forecast to 2030 (US$ Million)
9.2 Organ Specific Adult Stem Cell
  • 9.2.1 Overview
  • 9.2.2 Drug Toxicity and Efficacy Testing: South & Central America Organoids Market – Revenue and Forecast to 2030 (US$ Million)

10. South & Central America Organoids Market – South and Central America Analysis

10.1 South and Central America
  • 10.1.1 South & Central America Organoids Market Breakdown, by Key Country, 2023 and 2030 (%)
  • 10.1.1.1 South & Central America Organoids Market – Revenue and Forecast Analysis – by Country
  • 10.1.1.1 Brazil: South & Central America Organoids Market – Revenue and Forecast to 2030 (US$ Million)
    • 10.1.1.1.1 Brazil: South & Central America Organoids Market Breakdown, by Organ Type
    • 10.1.1.1.2 Brazil: South & Central America Organoids Market Breakdown, by Application
    • 10.1.1.1.3 Brazil: South & Central America Organoids Market Breakdown, by Source
  • 10.1.1.2 Argentina: South & Central America Organoids Market – Revenue and Forecast to 2030 (US$ Million)
    • 10.1.1.2.1 Argentina: South & Central America Organoids Market Breakdown, by Organ Type
    • 10.1.1.2.2 Argentina: South & Central America Organoids Market Breakdown, by Application
    • 10.1.1.2.3 Argentina: South & Central America Organoids Market Breakdown, by Source
  • 10.1.1.3 Rest of South and Central America : South & Central America Organoids Market – Revenue and Forecast to 2030 (US$ Million)
    • 10.1.1.3.1 Rest of South and Central America : South & Central America Organoids Market Breakdown, by Organ Type
    • 10.1.1.3.2 Rest of South and Central America : South & Central America Organoids Market Breakdown, by Application
    • 10.1.1.3.3 Rest of South and Central America : South & Central America Organoids Market Breakdown, by Source

11. Competitive Landscape

11.1 Heat Map Analysis
11.2 Company Positioning and Concentration

12. South & Central America Organoids Market Industry Landscape

12.1 Overview
12.2 Mergers and Acquisitions
12.3 Agreements, Collaborations, and Joint Ventures
12.4 New Product Launches
12.5 Expansions and Other Strategic Developments

13. Company Profiles

13.1 Cellesce
  • 13.1.1 Key Facts
  • 13.1.2 Business Description
  • 13.1.3 Products and Services
  • 13.1.4 Financial Overview
  • 13.1.5 SWOT Analysis
  • 13.1.6 Key Developments
13.2 InSphero
  • 13.2.1 Key Facts
  • 13.2.2 Business Description
  • 13.2.3 Products and Services
  • 13.2.4 Financial Overview
  • 13.2.5 SWOT Analysis
  • 13.2.6 Key Developments
13.3 Merck KGaA
  • 13.3.1 Key Facts
  • 13.3.2 Business Description
  • 13.3.3 Products and Services
  • 13.3.4 Financial Overview
  • 13.3.5 SWOT Analysis
  • 13.3.6 Key Developments
13.4 STEMCELL Technologies Inc
  • 13.4.1 Key Facts
  • 13.4.2 Business Description
  • 13.4.3 Products and Services
  • 13.4.4 Financial Overview
  • 13.4.5 SWOT Analysis
  • 13.4.6 Key Developments
13.5 Thermo Fisher Scientific Inc
  • 13.5.1 Key Facts
  • 13.5.2 Business Description
  • 13.5.3 Products and Services
  • 13.5.4 Financial Overview
  • 13.5.5 SWOT Analysis
  • 13.5.6 Key Developments

14. Appendix

14.1 About Business Market Insights

The List of Companies - South & Central America Organoids Market

  1. Cellesce
  2. InSphero
  3. Merck KGaA
  4. STEMCELL Technologies Inc
  5. Thermo Fisher Scientific Inc

 

south-america-organoids-market